Trelegy (fluticasone furoate, umeclidinium, and vilanterol inhalation powder)
for Chronic Obstructive Pulmonary Disorder

Trelegy Ellipta is an inhalation powder used for the maintenance treatment of COPD and asthma in adults. It contains a combination of fluticasone (a corticosteroid that reduces inflammation), umeclidinium (an anticholinergic that helps open airways), and vilanterol (a long-acting bronchodilator that relaxes airway muscles). Trelegy Ellipta is taken daily to improve breathing, prevent bronchospasms, and manage symptoms but is not a rescue medication for sudden breathing problems.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Chronic Obstructive Pulmonary Disorder - COPD